LivaNova's aura6000 system delivers synchronised electrical pulses to the hypoglossal nerve to prevent airways collapse in ...

LivaNova (Nasdaq:LIVN) announced today that it received FDA premarket approval (PMA) for its aura6000 neuromodulation system for sleep apnea.

A noninvasive neuromodulation therapy that sends electrical microcurrents through a person’s hand can enhance sleep quality and overall health in older adults, a new study finds. The therapy, which is ...

Emerging neurotechnologies—devices and techniques designed to collect information about the brain or affect its function—are becoming increasingly important due to scientific and technological ...

The University of Surrey is a global community of ideas and people, dedicated to life-changing education and research. We are ambitious and have a bold vision of what we want to achieve - shaping ...